Page 3 - Classv Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Triller The short-form video app will go public by merging with a special purpose acquisition company (SPAC), offering a fast-track to the stock exchange while avoiding some regulatory scrutiny. Over the past six months, the short-form video app Triller has gone from fledgling startup to rising TikTok competitor, with $37.5 million raised from investors and Hollywood dealmaker Ryan Kavanaugh at its helm. Now, Triller is about to go public. Triller will enter into an agreement to merge with a special purpose acquisition company (SPAC) by the end of the year, a source familiar with the situati...

AbCellera stock price shoots up 185% in its debut on the Nasdaq stock exchange Author of the article: Colin McClelland Publishing date: Dec 11, 2020  •  December 11, 2020  •  3 minute read  •  Scientists work in an AbCellera Biologics Inc. lab. Bamlanivimab, the drug developed by AbCellera and Eli Lily, was authorized last month by Health Canada and the U.S. Food and Drug Administration to treat mild-to-moderate symptoms of COVID-19. Photo by AbCellera Biologics Inc. Article content A Canadian biotech company that’s on the leading edge of COVID-19 therapies saw its stock ...